Client Collaborations

Monitor and provide guidance on U.S. Food and Drug Administration and Federal Trade Commission action as it relates to the marketing and sale of CBD products.

Drafted manufacturing and white labeling agreements and managed disputes and end of contract issues.

Assists plan sponsors with navigating through the numerous federal laws that apply to their group health plans, including the Affordable Care Act, ERISA, Medicare Part D, COBRA, HIPAA portability and privacy, USERRA, and mental health parity, as well as satisfying Internal Revenue Code nondiscrimination rules applicable to self-insured health plans.

Assists with Affordable Care Act compliance, including advising about applicable large employer status, restrictions on lifetime and annual limits, rescissions, required notices, and grandfathered plan rules.

Assists with COBRA issues and preparing and reviewing required COBRA notices, including issues related to qualifying events, duration of COBRA coverage, and correction of COBRA failures.

Assist plan sponsors with the federal laws that apply to their group health plans, including the ACA, COBRA, HIPAA, USERRA, Medicare Part D, nondiscrimination rules applicable to self-insured health plans, mandated coverage and benefits, and ERISA's trust requirement. Also assist plan sponsors with the issues involving the coverage of domestic partners, including plan design and tax consequences.

Counsel plan sponsors regarding compliance with the ACA, including the play or pay rules, health coverage reporting, the tax exclusion and required coverage of adult children, the grandfathered plan rules, the rules regarding excepted benefits, the restrictions on lifetime and annual limits, preexisting condition exclusions, rescissions, the required notices to participants, and the internal and external claims review process.  Helps plan sponsors respond to proposed penalties from the IRS for failing to offer health coverage or failing to do the required health coverage reporting. 

Advises plan sponsors on all aspects of COBRA. Prepares and reviews COBRA notices. Assists plan sponsors with COBRA administration issues, including issues relating to qualifying events, COBRA notices, the applicable premium, correction of COBRA failures, early termination of COBRA coverage, duration of COBRA coverage, special rules for health FSAs, COBRA in mergers and acquisitions, and the coordination of COBRA and USERRA coverage.

Represented publicly traded company in SEC and DOJ investigation into potential securities law violations resulting from accounting issues.

Represented publicly traded mutual fund company in SEC investigation involving allegedly false and misleading marketing materials.

Represented a multinational pharmaceutical company in DOJ and SEC investigations of alleged FCPA violations in numerous countries.